Collections
DOJ Antitrust Division Business Review Letters
2020
20-6
Eli Lilly and Company, AbCellera Biologics, Amgen, AstraZeneca, Genentech, and GSK
Antitrust Division, U.S. Department of Justice
Learn More
Log In
Sign Up
20-6
Expedited Business Review Letter (July 23, 2020)
20-6
Request Letter: Eli Lilly and Company, AbCellera Biologics, Amgen, AstraZeneca, Genentech, and GSK (July 15, 2020)